Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL147120 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL919280 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL6440343 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL38558 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL288384 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL5980144 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL38557 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL1468176 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL16635360 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 | |
| SCHEMBL1468174 | 0.98 | ALDH1A1 (0.49) | SMN1; SMN2ALDH1A1CYP3A4NPSR1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2785 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12358948-B2 | Neurotensinergic agonists and methods of using same preventing or treating pain | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2025-07-15 | — | — | US | claimed |
| US-20240382605-A1 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | US | claimed |
| CN-118510522-A | Conjugated oligonucleotides and uses thereof | IONIS制药公司 | 2024-08-16 | — | — | CN | claimed |
| EP-4408433-A1 | CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | Ionis Pharmaceuticals, Inc. (US) | 2024-08-07 | — | — | EP | claimed |
| EP-3169403-B9 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-07-03 | — | — | EP | claimed |
| EP-3169403-B1 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-02-14 | — | — | EP | claimed |
| EP-4313159-A1 | SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY | Feldan Bio Inc. (CA) | 2024-02-07 | — | — | EP | claimed |
| US-20230405134-A1 | NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION | POSTECH Research and Business Development Foundation (KR) | 2023-12-21 | — | — | US | claimed |
| CN-116789763-A | Permeable membrane polypeptide and application thereof in resisting colon cancer | 上海交通大学医学院 | 2023-09-22 | — | — | CN | claimed |
| EP-4232590-A1 | SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS | Feldan Bio Inc. (CA) | 2023-08-30 | — | — | EP | claimed |
| EP-0870198-A1 | RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR | COR THERAPEUTICS, INC. (US) | 1998-10-14 | — | — | EP | claimed |
| EP-0804452-A4 | RECOMBINANT C140 RECEPTOR AND ITS AGONISTS AND ANTAGONISTS | COR THERAPEUTICS INC (US) | 1998-08-12 | — | — | EP | claimed |
| US-5763575-A | DRUG SIDE EFFECT REDUCTION | COR THERAPEUTICS, INC. (US) | 1998-06-09 | — | — | US | claimed |
| EP-0804452-A1 | RECOMBINANT C140 RECEPTOR AND ITS AGONISTS AND ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1997-11-05 | — | — | EP | claimed |
| EP-0642531-B1 | MONOMER AND DIMER PEPTIDES, UTILIZATION AS CYTOPROTECTOR AGENTS AND PREPARATION METHOD | INST VAISSEAUX ET DU SANG (FR) | 1997-03-26 | — | — | EP | claimed |
| WO-1996023225-A9 | RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR | — | 1996-10-03 | — | — | WO | claimed |
| WO-1996023225-A1 | RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR | COR THERAPEUTICS, INC. (US) | 1996-08-01 | — | — | WO | claimed |
| EP-0642531-A1 | MONOMER AND DIMER PEPTIDES, UTILIZATION AS CYTOPROTECTOR AGENTS AND PREPARATION METHOD. | SERBIO (FR) | 1995-03-15 | — | — | EP | claimed |
| WO-1995003318-A1 | RECOMBINANT C140 RECEPTOR AND ITS AGONISTS AND ANTAGONISTS | COR THERAPEUTICS (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1993023426-A1 | MONOMER AND DIMER PEPTIDES, UTILIZATION AS CYTOPROTECTOR AGENTS AND PREPARATION METHOD | SERBIO (FR) | 1993-11-25 | — | — | WO | claimed |